Clinical Trials Directory

Trials / Completed

CompletedNCT00922623

Safety and Effectiveness of Belotero® in Subjects With Fitzpatrick Phototypes IV Through VI

A Multicenter Study of The Safety and Effectiveness of Dermal Filler, Belotero®, After Mid-to-Deep Dermal Implantation for Correction of Moderate to Severe Facial Wrinkles (Such as Nasolabial Folds) Over 24 Weeks in Subjects With Fitzpatrick Phototype Scores of IV, V, and VI.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
93 (actual)
Sponsor
Merz North America, Inc. · Industry
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This is a study to assess how safe and effective an investigational product, Belotero® is in people with all skin types with facial wrinkles, such as nasolabial folds. Nasolabial folds are wrinkles on the face that go from outside of the nostrils to the edges of the mouth.

Detailed description

The Fitzpatrick Skin Phototype Scale goes from number 1 (I), which is the very lightest skin tone, to number 6 (VI) which is the very darkest skin tone. This study is to determine the safety and effectiveness of Belotero® in people with skin phototypes of 1(I)thru 6 (VI).

Conditions

Interventions

TypeNameDescription
DEVICEBelotero®Hyaluronic acid dermal filler, Belotero®, single use syringe, injected into mid to deep dermal layer

Timeline

Start date
2009-05-01
Primary completion
2010-07-01
Completion
2010-07-01
First posted
2009-06-17
Last updated
2013-04-26
Results posted
2012-01-30

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00922623. Inclusion in this directory is not an endorsement.